Statement of Use

RSM

Finch Therapeutics, Inc.

Trademark/Service Mark Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1553 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88129597
LAW OFFICE ASSIGNED LAW OFFICE 110
EXTENSION OF USE YES
MARK SECTION
MARK http://tmng-al.gov.uspto.report/resting2/api/img/88129597/large
LITERAL ELEMENT RSM
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
OWNER SECTION
NAME Finch Therapeutics, Inc.
STREET 200 Inner Belt Road, Suite 400
CITY Somerville
STATE Massachusetts
ZIP/POSTAL CODE 02143
COUNTRY United States
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives in the nature of dietary supplements for medical purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use
GOODS OR SERVICES DELETE ALL ITU GOODS/SERVICES IN THIS CLASS OR PROCESS ACCORDING TO REQUEST TO DIVIDE
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION Research and development of microbiologics, immunotherapeutics, and other therapeutic agents; Development of pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use; Scientific research and development services relating to foods and dietary supplements; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
GOODS OR SERVICES KEEP ALL LISTED
FIRST USE ANYWHERE DATE 01/01/2018
FIRST USE IN COMMERCE DATE 01/01/2018
SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPN1-6520916146-20190722103629832294_._RSM_specimen.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT17\IMAGEOUT17\889\756\88975683\LM2Copy\88129597\1\SOU16\SOU2.JPG
SPECIMEN DESCRIPTION Screen shot from applicant's website that displays the mark in connection with the identified services
REQUEST TO DIVIDE YES
GOOD(S)/SERVICE(S) IN USE Class 42
GOOD(S)/SERVICES INTENT TO USE Class 5
PAYMENT SECTION
NUMBER OF CLASSES IN USE 1
SUBTOTAL AMOUNT [ALLEGATION OF USE FEE] 100
REQUEST TO DIVIDE FEE 100
TOTAL AMOUNT 200
SIGNATURE SECTION
DECLARATION SIGNATURE /Benjamin Enerson/
SIGNATORY'S NAME Benjamin Enerson
SIGNATORY'S POSITION VP & General Counsel
DATE SIGNED 07/23/2019
REQUEST TO DIVIDE SIGNATURE /rachelledubow/
SIGNATORY'S NAME Rachelle Dubow
SIGNATORY'S POSITION Attorney for Applicant, MA bar
DATE SIGNED 07/25/2019
SIGNATORY'S PHONE NUMBER 617-951-8000
AUTHORIZED SIGNATORY YES
FILING INFORMATION
SUBMIT DATE Thu Jul 25 17:12:41 EDT 2019
TEAS STAMP USPTO/SOU-XX.XXX.XX.XXX-2
0190725171241655254-88129
597-620b6c06c5251f4d6ef65
72c42037d55d940bdb297e5a7
72f7e4112d57557963-DA-365
2-20190722103629832294



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1553 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:
MARK: RSM(Standard Characters, see http://tmng-al.gov.uspto.report/resting2/api/img/88129597/large)
SERIAL NUMBER: 88129597
An Extension of Time form is being filed with the Allegation of Use.



The applicant, Finch Therapeutics, Inc., having an address of
      200 Inner Belt Road, Suite 400
      Somerville, Massachusetts 02143
      United States
is submitting the following allegation of use information:

For International Class 005:
Current identification: Pharmaceuticals used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives in the nature of dietary supplements for medical purposes; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms used to maintain health or restore health to a human or animal subject via treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use

All ITU goods/services in this class are to be deleted or processed according to a request to divide.


For International Class 042:
Current identification: Research and development of microbiologics, immunotherapeutics, and other therapeutic agents; Development of pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use; Scientific research and development services relating to foods and dietary supplements; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 01/01/2018, and first used in commerce at least as early as 01/01/2018, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) Screen shot from applicant's website that displays the mark in connection with the identified services.

Original PDF file:
SPN1-6520916146-20190722103629832294_._RSM_specimen.pdf
Converted PDF file(s) (1 page)
Specimen File1


REQUEST TO DIVIDE
The applicant is requesting to divide the application and specifies the following:
The following good(s) or service(s) is/are now in use: Class 42
The following good(s) or service(s) remain(s) under the Section 1(b), intent to use basis: Class 5

A fee payment in the amount of $100 will be submitted with the form, representing payment for the allegation of use for 1 class.

A fee payment in the amount of $100 will be submitted with the form, representing payment for the request to divide fee.


Declaration


The signatory believes that the applicant is the owner of the mark sought to be registered.
For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified.
For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified.
For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.
The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce.
To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.



Signature: /Benjamin Enerson/      Date Signed: 07/23/2019
Signatory's Name: Benjamin Enerson
Signatory's Position: VP & General Counsel

Request to Divide Signature


Signature: /rachelledubow/    Date: 07/25/2019
Signatory's Name: Rachelle Dubow
Signatory's Position: Attorney for Applicant, MA bar

Signatory's Phone: 617-951-8000


RAM Sale Number: 88129597
RAM Accounting Date: 07/26/2019

Serial Number: 88129597
Internet Transmission Date: Thu Jul 25 17:12:41 EDT 2019
TEAS Stamp: USPTO/SOU-XX.XXX.XX.XXX-2019072517124165
5254-88129597-620b6c06c5251f4d6ef6572c42
037d55d940bdb297e5a772f7e4112d57557963-D
A-3652-20190722103629832294



Statement of Use [image/jpeg]

Statement of Use [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed